Cyterix Pharmaceuticals Receives $9,200,000 Series A Funding Round

  • Feed Type
  • Date
    6/8/2011
  • Company Name
    Cyterix Pharmaceuticals
  • Mailing Address
    1300 Seaport Blvd. Redwood City, CA 94063
  • Company Description
    The company is developing cytochrome P450- activated drugs.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $9,200,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Continuing in our cash-efficient business model, we expect these funds to advance our two lead compounds through IND-enabling studies, as well as further expand the development of our technology platform and our exploration of new targets within the extra-hepatic cytochrome P450 enzyme family.
  • M&A Terms
  • Venture Investor
    The Column Group
  • Venture Investor
    SV Life Sciences

By posting a comment, you agree to our terms and conditions.